바로가기메뉴

본문 바로가기 주메뉴 바로가기
 
 

logo

  • ENGLISH
  • P-ISSN3022-6805
  • E-ISSN3022-6791
  • KCI

ISSN : 3022-6805

논문 상세

이전 다음
논문 투고

Vol.2 No.3

PDF Citation Share

Immunomodulatory properties of medicinal maggots Lucilia sericata in wound healing process

셀메드 / CELLMED, (P)3022-6805; (E)3022-6791
2012, v.2 no.3, pp.23-23
Jana Bohova (Slovak Academy of Sciences)
Juraj Majtan (Slovak Academy of Sciences)
Peter Takac (Slovak Academy of Sciences)
Jana, B. , Juraj, M. , & Peter, T. (2012). . , 2(3), 23-23.

Abstract

The healing properties of medicinal maggots (larval stage of Lucilia sericata) are widely used in the chirurgical debridement of non-healing wounds including diabetic foot ulcers, venous and pressure ulcers, where classical approaches have failed. Several kinds of wounds are prone to complications coming out of a specific wound bed environment. There are multi-resistant bacterial species present, their pathogenic impact is multiplied by their ability to form a biofilm. Moreover, immunological events in chronic wounds differ from those in acute wounds. Non-healing wounds are cycled in the early inflammation phase with increased levels of inflammation attributes like inflammation cytokines and matrix metalloproteinases produced by inflammation phase cells. Application of larval therapy promotes progress in the healing process to the next stages involving tissue granulation and re-epithelisation. Larval debridement is an effective method of cleaning the wound of cell debris, necrotic tissue and bacterial load. This happens in a mechanical and biological manner, but the whole complex mechanism of the maggot healing activity is still not fully elucidated. Centuries of clinical practice brings noticeable proof of the maggots’ beneficial effect in wound healing management. This long history led to the investigation of the bioactive components of the larval body and its extracts in vitro. We introduce a review which describes the immunomodulation impact of maggot body components on the cellular and molecular levels of the wound healing process.

keywords
wound healing, Lucilia, maggot debridement therapy

참고문헌

1.

Bello YM, Falabella AF, DeCaralho H, Nayyar G, Kirsner RS. Infection and wound healing. Wounds. 2001;13:127-131.

2.

Bendy RH Jr, Nuccio PA, Wolfe E, Collins B, Tamburro C, Glass W, Martin CM. Relationship of quantitative wound bacterial counts to healing of decubiti: Effect of topical gentamicin. Antimicrob Agents Chemother. 1964;104:147-155.

3.

Bexfield A, Bond AE, Morgan C, Wagstaff J, Newton RP, Ratcliffe NA, Dudley E, Nigam Y. Amino acid derivatives from Lucilia sericata excretions/secretions may contribute to the beneficial effects of maggot therapy via increased angiogenesis. Br J Dermatol. 2010;162:554-562.

4.

Bjarnsholt T, Kirketerp-Moller K, Jensen PO, Madsen KG, Phipps R, Krogfelt K, Hoiby, Givskov M. Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen. 2008;16:2-10.

5.

Bowler PG, Davies BJ. The microbiology of infected and noninfected leg ulcers. Int J Dermatol. 1999;38:573-578.

6.

Brem H, Stojadinovic O, Diegelmann RF, Entero H, Lee B, Pastar I, Golinko M, Rosenberg H, Tomic-Canic M. Molecular markers in patients with chronic wounds to guide surgical debridement. Mol Med. 2007;13:30-39.

7.

Bryant RA, Nix DP. Acute and Chronic Wounds: Current Management Concepts. (Maryland Heights, USA: Mosby Elsevier), 2007.

8.

Buc M. Imunologia. (Bratislava, Slovakia: Veda), 2001.

9.

Bullen EC, Longaker MT, Updike DL, Benton R, Ladin D, Hou Z, Howard EW. Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. J Invest Dermatol. 1995;104:236-240.

10.

Chraibi H, Dereure O, Teot L, Guillot B. The diagnosis and treatment of carcinomas occurring at the sites of chronic pressure ulcers. J Wound Care. 2004;13:447-448.

11.

Clark RAF. The molecular and cellular biology of wound repair. (NewYork, USA: Plenum Press), 1996.

12.

Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284:1318-1322.

13.

Costerton JW, Stewart PS. Battling biofilms. Sci Am. 2001;285:74-81.

14.

Diegelmann RF. Excessive neutrophils characterize chronic pressure ulcers. Wound Repair Regen. 2003;11:490-495.

15.

Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15:167-193.

16.

Dowd SE, Wolcott RD, Sun Y, McKeehan T, Smith E, Rhoads D. Polymicrobial Nature of Chronic Diabetic Foot Ulcer Biofilm Infections Determined Using Bacterial Tag Encoded FLX Amplicon Pyrosequencing (bTEFAP). PLoS ONE. 2008;3:e3326.

17.

Dumwille JC, Worthy G, Bland JM, Cullum N, Dowson C, Iglesias C, Mitchell JL, Nelson EA, Soares MO, Torgerson DJ. Larval therapy for leg ulcers (VenUS II): randomised controlled trial. BMJ. 2009;338:b773.

18.

Falabella A, Kirsner R. Wound healing (Basic and Clinical dermatology). 1st ed. (Florence, USA: Taylor & Francis), 2005.

19.

Gentilini D, Busacca M, Di Francesco S, Vignali M, Vigano' P, DiBlasio AM. PI3K/Akt and ERK1/2 signalling pathways are involved in endometrial cell migration induced by 17 beta-estradiol and growth factors. Mol Hum Reprod. 2007;13:317-322.

20.

Gordillo GM, Sen CK. Revisiting the essential role of oxygen in wound healing. Am J Surg. 2003;186:259-263.

21.

Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3:23-35.

22.

Granick MS, Gamelli RL. Surgical wound healing and management. (New York, USA: CRC Press), 2007.

23.

Jaklic D, Lapanje A, Zupancic K, Smrke D, Gunde-Cimerman N. Selective antimicrobial activity of maggots against pathogenic bacteria. J Med Microbiol. 2008;57:617-625.

24.

Jiang Q, Zhou C, Bi Z, Wan Y. EGF-induced cell migration is mediated by ERK and PI3K/AKT pathways in cultured human lens epithelial cells. J Ocul Pharmacol Ther. 2006;22:93-102.

25.

Kingston D, Seal DV. Current hypotheses on synergistic microbial gangrene. Br J Surg. 1990;77:260-264.

26.

Koh TJ, DiPietro LA. Inflammation and wound healing: the role of the macrophage. Expert Rev Mol Med. 2011;13:e23.

27.

Kosinsky MA, Lipsky BA. Current medical management of diabetic foot infections. Expert Rev Anti Infect Ther. 2010;8:1293-1305.

28.

Ladwig GP, Robson MC, Liu R, Kuhn MA, Muir DF, Schultz GS. Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Repair Regen. 2002;10:26-37.

29.

Lieu C, Heymach J, Overman M, Tran H, Kopetz S. Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis. Clin Cancer Res. 2011;17:6130-6139.

30.

Lobmann R, Schultz G, Lehnert H. Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications. Diabetes Care. 2005;28:461-471.

31.

Madsen SM, Westh H, Danielsen L, Rosdahl VT. Bacterial colonisation and healing of venous leg ulcers. Acta Path Micro Im B. 1996;104:895-899.

32.

Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection. Am J Infect Control. 1999;27:97-134.

33.

Menke NB, Ward KR, Witten TM, Bonchev DG, Diegelmann RF. Impaired wound healing. Clin Dermatol. 2007;25:19-25.

34.

Mirza R, Dipietro LAK TJ. Selective and specific macrophage ablation is detrimental to wound healing in mice. Am J Pathol. 2009;175:2454-2462.

35.

Nelzen O，Bergqvist D, Lindhagen A, Hallbook T. Chronic leg ulcers: an underestimated problem in primary health care among elderly patients. J Epidemiol Community Health. 1991;45:184-187.

36.

Nigam Y, Dudley E, Bexfield A, Bond AE, Evans J, James J. Advances in Insect Physiology. (Burlington, USA: Academic Press), 2010.

37.

Park JE, Barbul A. Understanding the role of immune regulation in wound healing. Am J Surg. 2004;187:11S-16S.

38.

Peciviva J, Macickova T, Takac P, Kovacsova M, Cupanikova D, Kozanek M. Effect of an extract from salivary gland of Lucilia sericata on human neutrophils. Neuro Endocrinol Lett. 2008;29:794-797.

39.

Prete PE. Growth effects of Phaenicia sericata larval extracts on fibroblasts: mechanism for wound healing by maggot therapy. Life Sci. 1997;60:505-510.

40.

Rivera AE, Spencer JM. Clinical aspects of fullthickness wound healing. Clin Dermatol. 2007;25:39-48.

41.

Rogers AA, Burnett S, Moore JC, Shakespeare PG, Chen WYJ. Involvement of proteolytic enzymes plasminogen activators and matrix metalloproteinases in the pathophysiology of pressure ulcers. Wound Repair Regen. 1995;3:273-283.

42.

Schultz GS. The physiology of wound bed preparation. In Surgical wound healing and management. Granick MS, Gamelli RL ed. (New York, USA: Informa Healthcare), 2007.

43.

Sherman RA. Maggot versus conservative debridement therapy for the treatment of pressure ulcers. Wound Repair Regen. 2002;10:208-214.

44.

Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med. 1999;341:738-746.

45.

Steenvoorde P, Jacobi CE, Van Doorn L, Oskam J. Maggot debridement therapy of infected ulcers: patient and wound factors influencing outcome - a study on 101 patients with 117 wounds. Ann R Coll Surg Engl. 2007;89:596-602.

46.

Tarnuzzer RV, Schultz GS. Biochemical analysis of acute and chronic wound environment. Wound Repair Regen. 1996;4:321-325.

47.

Trengove NJ, Stacey MC, MacAuley S, Bennett N, Gibson J, Burslem F, Murphy G, Schultz G. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen. 1999;7:442-452.

48.

Vaalamo M, Weckroth M, Puolakkainen P, Kere J, Saarinen P, Lauharanta J, Saarialho- Kere UK. Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds. Br J Dermatol. 1996;135:52-59.

49.

van der Plas MJ, van der Does AM, Baldry M, Dogterom-Ballering HC, van Gulpen C, van Dissel JT, Nibbering PH, Jukema GN. Maggot excretions/secretions inhibit multiple neutrophil pro-inflammatory responses. Microbes Infect. 2007;9:507-514.

50.

van der Plas MJ, Baldry M, van Dissel JT, Jukema GN, ibbering PH. Maggot secretions suppress pro-inflammatory responses of human monocytes through elevation of cyclic AMP. Diabetologia. 2009a;52:1962-1970.

51.

van der Plas MJ, van Dissel JT, Nibbering PH. Maggot secretions skew monocyte-macrophage differentiation away from a pro-inflammatory to a pro-angiogenic type. PLoS One. 2009;4:e8071.

52.

Velnar T, Bailey T, Smrkolj V. The wound healing process: an overview of the cellular and molecular mechanism. J Int Med Res. 2009;37:1528-1542.

53.

Wang SY, Wang K, Xin Y, Ly DC. Maggot excretions/secretions induces human microvascular endothelial cell migration through AKT1. Mol Biol Rep. 2010;37:2719-2725.

54.

Xu W, Roos A, Schlagwein N, Woltman AM, Daha MR, van Kooten C. IL-10- producing macrophages preferentially clear early apoptotic cells. Blood. 2006;107:4930-4937.

55.

Yager DR, Kulina RA, Gilman LA. Wound fluids: A window into the wound environment. Int J Low Extrem Wounds. 2007;6:262-272.

56.

Yager DR, Nwomeh BC. The proteolytic environment of chronic wounds. Wound Repair Regen. 1999;7:433-441.

57.

Zarchi K, Jamec GB. The efficacy of maggot debridement therapy - areview of comparative clinical trials. Int Wound J. 2012;9:469-477.

58.

Zhang Z, Wang S, Diao Y, Zhang J, Lv D. Fatty acid extracts from Lucilia sericata larvae promote murine cutaneous wound healing by angiogenic activity. Lipids Health Dis. 2010;8:9-24.

셀메드

논문 투고 OA 정책